Germany’s Expert Advisory Committee for Prescription has given the green light to three new prescription-to-OTC reclassifications, following a strong show of support by consumers and pharmacists for more switches in the country.
Earlier this month, the Expert Committee – which recommends, where appropriate, prescription-to-OTC reclassifications as well as OTC-to-prescription reverse-switches to the...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?